Am.  Jour.  Pharm.  \ 
September,  1901.  J 
International  Congresses . 
441 
The  perennial  question  of  an  international  pharmacopoeia  seemed 
to  have  lost  much  in  interest.  Professor  Remington  read  a  paper  on 
the  relations  between  pharmacists  and  physicians  in  connection  with 
pharmacopoeial  revisions  ;  he  advocated  the  principle  of  differentiat- 
ing the  domain  of  the  practitioner  of  pharmacy  and  that  of  the 
practitioner  of  medicine  as  being  an  efficient  means  of  promoting 
the  interests  of  pharmacy  and  the  mutual  relations  of  the  pharma- 
cist and  physician  in  their  professional  bearings  as  well  as  in  the 
work  of  the  revision  of  the  pharmacopoeia. 
Professor  Remington  also  read  a  brief  report  as  chairman  of  a 
standing  committee  of  three  appointed  at  the  Congress  meeting  in 
Chicago  in  1893,  consisting  of  Messrs.  Remington,  of  Philadelphia  ; 
Carteighe,  of  London,  and  Waldheim,  of  Vienna,  stating  that  in  con- 
sequence of  the  illness  of  the  latter,  and  the  great  difficulties  in 
corresponding  with  associations  and  authorities  in  distant  countries, 
little  progress  had  been  made. 
The  suggestion  made  prevailed  r>  that  it  might  be  a  subservient 
step  towards  attaining  to  a  greater  uniformity  in  the  pharmacopoeial 
formulae  to  have  an  international  committee  of  prominent  pharma- 
cists as  an  advisory  body  for  co-operation  with  the  committees  of 
pharmacopoeial  revision  in  the  various  countries;  and  that  in  any 
such  work  a  larger  representation  of  practical  pharmacists  and 
teachers  of  pharmaceutical  branches  was  desirable. 
Questions  4,  5  and  6  were  only  briefly  discussed  as  somewhat 
irrelevant  and  of  less  interest  and  consequence.  In  regard  to  organo. 
therapeutic  remedies  it  was  considered  as  impracticable  to  establish 
definite  rules  inasmuch  as  their  active  principles  as  yet  are  insuffi- 
ciently known  and  as  their  therapeutic  action  can  only  be  estimated 
by  physiological  tests  and  much  less  by  analytical  examination. 
In  regard  to  the  newer  remedies  the  following  resolutions  offered 
by  Mr.  Hayn,  of  Antwerp,  were  adopted  : 
(1)  That  the  distinctive  properties  and  reactions  of  each  new  remedy  should 
be  published  on  the  label  and  in  all  circulars  relating  to  the  remedy. 
(2)  That  central  laboratories  be  established  for  the  analysis  and  control  of 
new  remedies. 
(3)  A  standing  committee  for  the  study  and  examination  of  all  new  medici- 
nal products  should  be  established,  the  members  of  which  should  be  appointed 
by  the  different  governments  from  the  members  of  the  academies  of  medicine 
or  of  pharmacopoeia  committees. 
(4)  There  should  be  an  official  control  and  verification  of  serums  and  the 
.  various  glandular  juices,  etc. 
